Related Experiment Video
Updated: Jan 26, 2026

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
Cos-Seq: A High-Throughput Gain-of-Function Screen for Drug Resistance Studies in Leishmania
Jade-Eva Potvin1, Philippe Leprohon1, Elodie Gazanion2
1Département de Microbiologie, Infectiologie et Immunologie, Faculté de Médecine, Centre de Recherche en Infectiologie du Centre de Recherche du CHU de Québec, Université Laval, Québec, QC, Canada.
Abstract:
Leishmania is still a major cause of mortality and morbidity worldwide. Few efficient drugs are available, and resistance threatens actual treatments. In order to improve knowledge about the mode of action of current drugs and those in development, as well as to understand the mechanisms pertaining to their resistance, we recently described a sensitive and high-throughput method termed Cos-Seq. Here we provide a detailed protocol for every step of the procedure, from library construction to drug selection, cosmid extraction, and next-generation sequencing of extracted cosmids. A section on the bioinformatics of Cos-Seq is also included. Cos-Seq facilitates the identification of gain-of-function resistance mechanisms and drug targets and is a useful tool in resistance and drug development studies.
Insights
Leishmania parasites cause significant global health issues. A new method, Cos-Seq, aids in understanding drug resistance and developing new treatments for Leishmania infections.
Area of Science:
- Parasitology
- Molecular Biology
- Drug Discovery
Background:
- Leishmania infections represent a significant global health burden, causing widespread mortality and morbidity.
- Existing treatments for Leishmania are limited, and the emergence of drug resistance poses a serious threat to their efficacy.
- A deeper understanding of drug mechanisms and resistance pathways is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To provide a detailed protocol for the Cos-Seq method, a sensitive and high-throughput technique.
- To facilitate the identification of drug targets and mechanisms of drug resistance in Leishmania.
- To support ongoing research in drug development and resistance studies for Leishmania.
Main Methods:
- Detailed step-by-step protocol for Cos-Seq, including library construction and drug selection.
- Cosmid extraction and subsequent next-generation sequencing of extracted cosmids.
- Bioinformatic analysis tailored for Cos-Seq data.
Main Results:
- Cos-Seq enables the identification of gain-of-function resistance mechanisms.
- The method facilitates the discovery of novel drug targets.
- Cos-Seq is a valuable tool for studying drug resistance and development in Leishmania.
Conclusions:
- The Cos-Seq protocol offers a comprehensive approach for investigating Leishmania drug resistance.
- This method enhances the understanding of how Leishmania parasites develop resistance to drugs.
- Cos-Seq is instrumental in advancing the development of new and effective treatments against Leishmania.
Related Concept Videos
Gain
Gain:
Suppose Vin is the input and Vout is the output signal to a circuit.
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Resistivity
Resistance
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
Methods for Studying Drug Absorption: In vitro
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...

